To further confirm if TIAM1 exhibited SSV-gene-like functional properties, we assessed the impact of the treatment of HCC cell lines and normal HHL5 cells with the inhibitor NSC23766. This evidence concerns the gene TIAM1 and hepatocellular carcinoma.